Cervical Pain
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
2 programs1
Intracervical Lidocaine InjectionPhase 41 trial
Nitroprusside GelN/A1 trial
Active Trials
Spine BioPharmaNY - New York
1 programNeck exercises using both manual and Thera-Band elasatic resistanceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Oregon TherapeuticsIntracervical Lidocaine Injection
Spine BioPharmaNeck exercises using both manual and Thera-Band elasatic resistance
Oregon TherapeuticsNitroprusside Gel
Clinical Trials (3)
Total enrollment: 128 patients across 3 trials
Tenaculum Pain Control Study
Start: Sep 2011Est. completion: May 201274 patients
Phase 4Completed
Cervical Activation During Elastic and Manual Resistance
Start: Apr 2014Est. completion: Aug 201430 patients
N/ACompleted
The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion
Start: Dec 2010Est. completion: Jul 201124 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.